quinazolines has been researched along with Corneal Neovascularization in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akpolat, N; Bulut, H; Demir, T; Kaya, MK; Turgut, B | 1 |
1 other study(ies) available for quinazolines and Corneal Neovascularization
| Article | Year |
|---|---|
Effects of lapatinib and trastuzumab on vascular endothelial growth factor in experimental corneal neovascularization.
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Corneal Neovascularization; Corneal Stroma; Disease Models, Animal; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Epithelium, Corneal; Injections, Intraperitoneal; Lapatinib; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Wistar; Trastuzumab; Vascular Endothelial Growth Factor A | 2015 |